An expert from GeoVax discusses how China may be poised to overtake the US as the world leader in the industry.

Starting next fall, students at Texas A&M will be able to enroll in a new major in the College of Arts and Sciences: a ...

Following a restructuring of the university over the summer into distinct but cross-collaborative schools, Brandeis rolled ...

Entrada Therapeutics reported a 3Q25 GAAP EPS loss of –$1.06 and revenue of $1.6 million, reflecting declining collaboration ...

After dropping so-so early-stage results on its dual GLP-1/GLP-2 agonist earlier this year, fierce competition in the obesity ...

Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step toward translating ...

The Bret Talley Scholarship for Future Tech Pioneers proudly announces the opening of applications for its fourth annual award, continuing its mission to identify and empower the next generation of ...

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

The University of Southern Queensland (UniSQ) is entering a new era, preparing for the future by investing in and nurturing ...

The decision to pause dapiglutide will help Zealand focus investment into assets that have “the greatest potential for ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Having grown up in a house of science and done research in labs more focused on basic research than cash cow drug discovery, I had a very noble view of science as a way to better understand our world.